EIF4G1 and non-small cell lung carcinoma: In the current study, we explore the clinical implications of EIF4G1 by using NSCLC tissue microarrays and other clinical databases, determine the efficacy of selective EIF4G1 inhibitors in NSCLC xenograft models and identify new EIF4G1‐controlled cellular proteins in NSCLC cells as well as validating their functions.